Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Biochem Mol Toxicol ; 26(9): 354-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22811316

ABSTRACT

This work investigated the effects of copper as preventive treatment against mercury-induced alterations in young rats. Wistar rats were treated (subcutaneous) with saline or CuCl(2) · 2H(2) O (6.9 mg/kg/day) from 3 to 7 days old and with saline or HgCl(2) (5.0 mg/kg/day) from 8 to 12 days old. Rats were sacrificed 24 h after the last dose. Mercury-exposed rats presented inhibition of liver (43%) and kidney (52%) porphobilinogen (PBG)-synthase activity and serum lactic dehydrogenase activity (50%). Also, an increase of the serum creatinine and urea levels around threefold and fivefold was observed, respectively. Pre-exposure to copper partially prevented the mercury effect on liver but not on kidney PBG synthase, and prevented the increase of the creatinine levels. Blood and brain PBG synthase and serum alanineaminotransferase activities, as well as glycemia, and liver glycogen content were not altered by treatments. These results show that copper, although being an essential metal, is inefficient as a preventive agent against mercury poisoning in parameters investigated after the end of mercury exposure.


Subject(s)
Copper/pharmacology , Mercuric Chloride/toxicity , Protective Agents/pharmacology , Animals , Animals, Newborn , Anoctamins , Blood Glucose , Blood Urea Nitrogen , Body Weight/drug effects , Brain/enzymology , Chloride Channels , Copper/therapeutic use , Creatinine/blood , Dose-Response Relationship, Drug , Glycogen/metabolism , Kidney/drug effects , Kidney/enzymology , Liver/drug effects , Liver/enzymology , Organ Size/drug effects , Porphobilinogen Synthase/blood , Porphobilinogen Synthase/metabolism , Protective Agents/therapeutic use , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...